News - Immunomedics

Filter

Current filters:

Immunomedics

Popular Filters

Immunomedics' milatuzumab a possible breakthrough for graft-versus-host disease

10-10-2012

US biotech firm Immunomedics (Nasdaq: IMMU), company primarily focused on the development of monoclonal…

BiotechnologyImmunologicalsImmunomedicsmilatuzumabResearch

Potential new treatment regimen for non-Hodgkin lymphoma from Immunomedics

13-06-2012

US biopharmaceutical company Immunomedics (Nasdaq: IMMU) has reported initial clinical experience with…

ImmunomedicsOncologyPharmaceuticalResearchveltuzumabyttrium-90

UCB and Immunomedics amend epratuzumab accord

29-12-2011

New Jersey, USA-based Immunomedics (Nasdaq: IMMU) and Belgian drugmaker UCB (Euronext Brussels: UCB)…

epratuzumabImmunologicalsImmunomedicsLicensingPharmaceuticalRare diseasesUCB

Back to top